V. C. Souza

发表

A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC).

A. Sasse, M. Santoni, A. Fay, 2022, Clinical genitourinary cancer.

Updates in head and neck cancer: one year in review

L. Kowalski, W. William, G. Castro, 2018 .

Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities

R. Reis, F. Schutz, L. Nogueira, 2021, International braz j urol : official journal of the Brazilian Society of Urology.

Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries

A. Sasse, P. Salman, D. Herchenhorn, 2021, JCO global oncology.

A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415).

O. Smaletz, F. Cárcano, F. Franke, 2021, European journal of cancer.

"Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil".

O. Smaletz, G. Carvalhal, A. Sasse, 2022, Clinical genitourinary cancer.

Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery

G. Carvalhal, A. Sasse, M. Maia, 2019, Therapeutic advances in urology.

Current topics on prostate and bladder pathology

D. Athanazio, V. C. Souza, 2018, Surgical and Experimental Pathology.

Second brazilian consensus on the treatment of advanced prostate cancer: a SBOC-SBU-SBRT panel review

O. Smaletz, G. Carvalhal, A. Sasse, 2019, International braz j urol : official journal of the Brazilian Society of Urology.

Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)

G. Carvalhal, A. Sasse, M. Maia, 2020, Journal of Cancer Research and Clinical Oncology.

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

C. Porta, O. Fiala, J. Bellmunt, 2023, Cancer Immunology, Immunotherapy.

Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update

O. Smaletz, A. Sasse, D. Herchenhorn, 2024, Journal of cancer research and clinical oncology.